Executive Summary
McKenzie Advanced Diagnostics is a clinical pathology laboratory founded by Abel McKenzie. The laboratory is registered as a Professional Corporation in Florida.
We operate in the Tampa area and service physicians, healthcare facilities, and individual patients with clinical pathology needs.
Personal medicine is a growing segment in clinical pathology. We aim to capitalize on this segment by offering personalized diagnostics to improve overall health.
McKenzie Advanced Diagnostics is seeking $320,000 in start-up or growth capital to fund operations, marketing, and staffing in the first 12 months.
Financial highlights:
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Revenue | $520,000 | $780,000 | $1,050,000 |
| Gross margin | 54% | 54% | 54% |
| Net profit / (loss) | ($23,600) | $2,400 | $31,500 |
Company Overview
McKenzie Advanced Diagnostics is a clinical pathology laboratory based in Tampa, Florida.
The business is set to launch in January next year. We will be prepared for operations in December to ensure everything flows smoothly once we launch and take clients. McKenzie Advanced Diagnostics is partnered with hospitals and healthcare facilities around Tampa to perform clinical pathological services for their patients.
McKenzie Advanced Diagnostics was founded as a Professional Corporation registered in Florida by Abel McKenzie. The high population growth in Tampa will foster quick growth for McKnezie Advanced Diagnostics.
Our target market is medical facilities within Tampa and closely surrounding areas. Our mission is to provide accurate, timely, and accessible services to our customers. Our vision is to make leaps in diagnostic pathology in Tampa. We aim to use the latest technology on the market to not only speed up our diagnostic process but also perform procedures that have not been possible before.
We offer a host of clinical pathology services, ranging from hematology to molecular diagnosis. We aim to raise our launch a strong brand identity and gain a foothold in the industry in our first year. We will re-evaluate and set more specific goals at the end of this period.
Legal structure: Professional Corporation (PC)
Mission: To deliver exceptional clinical pathology laboratory services to clients in Tampa, Florida, USA, building long-term relationships through quality, reliability, and deep expertise.
Objectives:
- Year 1: Establish operations, reach initial revenue target of $520,000, and build a loyal client base
- Year 2: Expand service capacity, grow revenue to $780,000, and hire additional staff
- Year 3: Achieve operational profitability, strengthen market position, and evaluate expansion opportunities
Market & Customer Analysis
The global pathology laboratory market was valued at $386 billion this year. The US market accounted for $96 billion of that figure. The industry has a CAGR of 8.3% for the 2024-2034 period and is expected to reach $214 billion by the end of this time.
The clinical pathology laboratory industry focuses on the diagnosis, treatment, and prevention of disease through the analysis of bodily fluids.
The industry’s overall growth can be attributed to the increasing number of healthcare facilities worldwide. The increasing elderly population and occurrence of chronic diseases are further driving market development.
The North American segment, comprising the United States of America and Canada, makes up 36% of the global clinical pathology laboratory market. It is followed by Europe at 30%, Asia Pacific at 27%, Latin America at 5%, and other regions at 2%. From this, it is evident that North America's market is competitive.
New entrants face long-standing competitors in the industry. Cost pressures is one of the barriers in this market, and it is easy for large laboratories to access cutting-edge technology that will gain them favor with customers.
The key to gaining a foothold in this industry is to be specific with services offered and to secure a customer base as soon as possible. Partnering with healthcare facilities to be their clinical pathology laboratory of choice is a must.
McKenzie Advanced Diagnostic’s unique selling proposition is that we cater to underserved clinical and anatomical pathology segments. Interest in personal medicine is booming in the North American market, and the supply is not yet matching. Pathology laboratories need to capitalize on this market driver and offer services catered to this emerging interest.
Customer analysis:
The clinical pathology market has a few customer segments. Our analysis revealed the following.
Individual patients are the largest segment. This segment is characterized by walk-in patients, individuals doing routine diagnostic checks, and those interested in personalized medicine.
This segment covers the child, adult, and senior demographic. They need convenience, affordable rates, accurate results, and fast turnaround time.
Physicians are the second largest source of revenue for clinical pathology laboratories. Physicians refer their patients to clinical pathology laboratories in the diagnostic process. This segment also values quick turnaround time and accurate results. Moreso, the value consistency. Offering specialized services is an advantage.
Competitor analysis:
| Competitor | Strengths | Weaknesses |
|---|---|---|
| Quest Diagnostics | Established brand, wide reach | Higher price point, less personalised |
| LabCorp | Strong marketing, national presence | Generic offering, less specialist focus |
| BioReference Laboratories | Competitive pricing | Lower service quality, limited expertise |
McKenzie Advanced Diagnostics's competitive edge: Specialist expertise, personalised service, and a clear focus on the underserved segment of the market set us apart from the established players listed above.
SWOT analysis:
| Positive | Negative | |
|---|---|---|
| Internal | Strengths: Specialist expertise; experienced founder; strong client relationships; differentiated positioning | Weaknesses: Limited brand recognition as a new entrant; single location; reliance on founder capacity in early years |
| External | Opportunities: Growing market demand; underserved niche segments; digital marketing reach; referral network growth | Threats: Established competitors with greater resources; economic downturn reducing discretionary spend; regulatory changes |
Sales & Marketing Plan
McKenzie Advanced Diagnostics provides clinical pathology services to physicians and patients in and around Tampa.
All of our operations occur on our premises in Tampa. We have all the equipment needed to perform standard and advanced diagnostic tests, and our clients value that we do not have to outsource any functions.
We have varying customer segments, each with needs and sales approach.
We prioritize partnering with physicians and healthcare facilities as they provide a steady source of revenue through patient referrals. We offer all physicians and healthcare facilities competitive rates and discounted prices on long-term agreements. This segment also requires integration with their EHR systems, which we offer.
Our primary short-term sales goal is to build a client base of 30-50. These will be in the form of contracts with physicians and healthcare facilities. Our medium-term goal is to increase our specialized services, particularly genetic and well-being testing. This aligns with our goal to increase our individual patient segment by 30%. Our long-term goal is to establish ourselves as the preferred clinical pathology laboratory for 15 healthcare facilities in Tampa.
The McKenzie Advanced Diagnostics sales team comprises sales representatives, account managers, and a customer service team.
Pricing strategy: Pricing is set to be competitive within the Tampa, Florida, USA market while reflecting the quality and specialist nature of the services delivered. All pricing is reviewed annually against market benchmarks.
Marketing channels:
- Digital presence (website + SEO) — professional website with content marketing to attract organic search traffic from clients searching for clinical pathology laboratory services in Tampa, Florida, USA
- Social media — active presence on relevant platforms to build brand awareness and engage prospective clients
- Referral programme — incentivised referral programme for existing clients; target 30% of new clients via referral by end of Year 2
- Local networking and partnerships — attendance at industry events and partnerships with complementary businesses in Tampa, Florida, USA
- Google Ads — targeted paid search campaigns for high-intent keywords during launch phase
Marketing budget Year 1: $26,000 (5% of projected revenue)
Additional marketing notes:
Our annual marketing budget is $146,250. We split the funds between a few marketing activities across four marketing categories.
The first marketing category McKenzie Advanced Diagnostics uses is digital marketing. 40% of our marketing budget goes towards digital marketing and is split in the following way:
- Website $5,850 (4)
- SEO: $8,775 (6)
- Pay Per Click Advertising: $14,625 (10)
- Social Media Advertising: $17,550 (12)
- Email Marketing: $5,850 (4)
- Content Creation: $5,850(4)
20% of our marketing budget goes toward traditional marketing and is allocated as follows:
- Print advertising: $8,775(6)
- Business cards and flyers $5,850(4)
- Networking events: $14,625 (10)
10% of our marketing budget goes toward public relations and is allocated as follows:
- Charity and donations: $5,850(4)
- Brand partnerships: $8,775 (6)
The 5% of the marketing budget is allocated for miscellaneous costs. The remaining 25% goes toward the marketing team’s performance bonus.
Operating Plan
Organizational Goal/Objective Business Area Responsible Party Activity Timeline Comply with CLIA and CAP laboratory regulations. Facility Management COO, Facility Manager, Lab Technicians
- Acquire laboratory space
- Install and calibrate lab equipment Months 1-3 Ensure relevant regulatory compliance. Regulatory Compliance CCO, Compliance Team, HR
- Obtain required licenses and certifications such as CLIA, CAP, and HIPAA Months 1-4 Build and maintain a qualified team. Staffing CHRO, Department Heads
- Hire administrative staff, technicians, and pathologists
- Train and onboard staff Months 2-4 Maintain data security and implement automation systems. Technology CTO, IT Team
- Implement and maintain the Laboratory Information System
- Integrate Electronic Health Record System Months 3-6
Staffing plan:
| Role | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Dr. Abel McKenzie (Owner / Director) | Full-time | Full-time | Full-time |
| Operations / Senior Staff | Part-time | Full-time | Full-time |
| Support / Junior Staff | — | Part-time | Full-time |
Legal & compliance:
- All required licences and permits for clinical pathology laboratory operations in Tampa, Florida, USA
- Professional liability and general liability insurance
- Data protection compliance in accordance with applicable laws
- Health & safety policies and risk assessments in place before trading begins
Management Team
Founder and Chief Executive Officer, Dr. Abel McKenzie.
Abel has 15 years of experience in clinical pathology laboratories, 10 of which were in leadership positions. He is a pathologist who graduated from the Yale School of Medicine. He also holds an MBA in Healthcare Management.
Chief Operator Office, Bianca Sanchez.
Bianca is a certified medical laboratory scientist with a bachelor’s in Laboratory Science. She has 6 years of experience in laboratory operations.
Chief Financial Offer, Domingo Hernandez.
Domingo is a certified financial analyst with a bachelor’s degree in finance. He also holds a master’s degree in finance. He has 10 years of experience managing finances for medical laboratories.
Chief Medical Officer, Dr. Perry Ivanov.
Dr. Ivanov is a medical doctor with a specialization in clinical pathology. She has 15 years of experience in medical laboratory leadership.
Chief Compliance Officer, Kayleigh Louw.
Kayleigh is an attorney specializing in healthcare compliance. She has worked for various healthcare regulatory bodies for over 15 years. She will now be joining McKenzie Advanced Diagnostics on the healthcare facility side. Her knowledge of the regulatory systems will ensure McKenzie Advanced Diagnostics' complete compliance.
Dr. Abel McKenzie — Founder & Director
Advisory support: The business will engage an experienced accountant and a business mentor through the local enterprise support network to provide financial oversight and strategic guidance during the first three years of trading.
Financial Plan
Projected Profit or Loss Statement
Year 1 Year 2 Year 3 Sales $90,000 $170,000 $300,000 Direct Cost of Sales $20,500 $30,000 $82,000 Production Payroll $0 $0 $0 Other $0 $0 $0 Total Cost of Sales $20,500 $30,000 $82,000 Gross Margin $69,500 $140,000 $218,000 Gross Margin % 77% 82% 73% Operating Expenses
Sales and Marketing Expenses
Sales and Marketing Payroll $20,000 $40,000 $40,000 Advertising/Promotion $800 $1,000 $1,000 Travel $0 $0 $0 Miscellaneous $500 $500 $500 Total Sales and Marketing Expenses $21,300 $41,500 $41,500 General and Administrative Expenses
General and Administrative Payroll $20,000 $40,250 $100,250 Sales and Marketing and Other Expenses $0 $0 $0 Depreciation $1,000 $1,000 $1,000 Dues and Subscriptions $200 $200 $200 Professional Fees $300 $300 $300 Rent $2,000 $2,000 $2,000 Software Purchases $0 $15,000 $0 Insurance $2,000 $2,000 $2,000 Telephone and Internet Access $2,000 $2,000 $2,000 Utilities $400 $400 $400 Miscellaneous $0 $0 $0 Payroll Taxes $500 $1,200 $3,000 Other General and Administrative Expenses $0 $0 $0 Total General and Administrative Expenses $28,400 $64,350 $111,150 Other Expenses:
Other Payroll $0 $0 $0 Consultants $0 $0 $0 Contract/Consultants $0 $0 $0 Total Other Expenses $0 $0 $0 Total Operating Expenses $28,400 $64,350 $111,150 Profit Before Interest and Taxes $19,800 $102,840 $225,410 EBITDA $19,800 $103,860 $226,430 Interest Expense $800 $3,632 $2,957 Taxes Incurred $0 $24,802 $56,540 Net Profit $19,000 $34,150 $65,350 Net Profit/Sales 21% 20% 22%
Projected Cash Flow Statement Cash Received Year 1 Year 2 Year 3 Cash from Operations
Cash Sales $90,000 $170,000 $300,000 Cash from Receivables $0 $0 $0 Subtotal Cash from Operations $90,000 $170,000 $300,00 Additional Cash Received
Sales Tax, VAT, HST/GST Received $0 $0 $0 New Current Borrowing $20,000 $0 $0 New Other Liabilities (interest-free) $0 $0 $0 New Long-term Liabilities $0 $0 $0 Sales of Other Current Assets $0 $0 $0 Sales of Long-term Assets $0 $0 $0 New Investment Received $0 $0 $0 Subtotal Cash Received $110,000 $170,000 $300,000 Expenditures
Expenditures from Operations
Subtotal Spent on Operations $48,900 $94,350 $111,150 Additional Cash Spent
Sales Tax, VAT, HST/GST Paid Out $800 $0 $0 Principal Repayment of Current Borrowing $10,000 $10,000 $0 Other Liabilities Principal Repayment $0 $0 $0 Long-term Liabilities Principal Repayment $0 $0 $0 Purchase Other Current Assets $0 $0 $0 Purchase Long-term Assets $0 $0 $0 Dividends $0 $0 $0 Subtotal Cash Spent $59,700 $104,350 $193,150 Net Cash Flow $50,300 $65,650 $106,850 Cash Balance $19,000 $34,150 $65,350 Projected Balance Sheet Assets Year 1 Year 2 Year 3 Current Assets
Cash $90,000 $170,000 $300,000 Accounts Receivable $0 $0 $0 Other Current Assets $0 $0 $0 Total Current Assets $90,000 $170,000 $300,000 Long-term Assets $10,000 $9,000 $8,000 Accumulated Depreciation $1,000 $1,000 $1,000 Total Long-term Assets ($1,000) ($1,000) ($1,000) Total Assets $100,000 $179,000 $308,00 Liabilities and Capital
Current Liabilities
Accounts Payable $0 $0 $0 Current Borrowing $20,000 $10,000 $0 Other Current Liabilities $0 $0 $0 Subtotal Current Liabilities $20,000 $10,000 $0 Long-term Liabilities $0 $0 $0 Total Liabilities $20,000 $10,000 $0 Paid-in Capital $30,000 $30,000 $30,000 Retained Earnings ($20,000) ($30,000) $41,000 Earnings ($12,000) $44,000 $160,000 Total Capital ($2,000) $44,000 $231,000 Total Liabilities and Capital $18,000 $54,000 $231,000 Net Worth $80,000 $169,00 $308,000
Wrapping up the Medical Laboratory Business Plan We’re sad to see you go, but we’ve reached the end of the medical laboratory business plan.
This is an all-inclusive guide to writing a business plan for your medical laboratory business. We covered each part of a business plan and added some examples to help you visualize. Now, it’s up to you to make that business idea a reality!
If you’ve ended up here but don’t have a medical laboratory business, don’t worry. Check out our other business plan templates for other industries here.
3-year profit & loss projection:
| Year 1 | Year 2 | Year 3 | |
|---|---|---|---|
| Revenue | $520,000 | $780,000 | $1,050,000 |
| Reagents, consumables and lab staff costs | $239,200 | $358,800 | $483,000 |
| Gross profit | $280,800 | $421,200 | $567,000 |
| Gross margin | 54% | 54% | 54% |
| Salaries and wages | $187,200 | $280,800 | $378,000 |
| Marketing and advertising | $26,000 | $39,000 | $52,500 |
| Rent and utilities | $60,000 | $60,000 | $63,000 |
| Other operating costs | $31,200 | $39,000 | $42,000 |
| Total operating expenses | $304,400 | $418,800 | $535,500 |
| Net profit / (loss) | ($23,600) | $2,400 | $31,500 |
Break-even analysis:
- Estimated fixed monthly costs: $23,200
- To cover fixed costs, McKenzie Advanced Diagnostics needs to generate approximately $43,000 in monthly revenue
- Break-even is projected to be reached in Month 9 of trading
Key financial assumptions:
- Revenue growth of 50% in Year 2 and 34% in Year 3 based on planned capacity expansion and marketing investment
- Reagents, consumables and lab staff costs estimated at 46% of revenue throughout the forecast period, consistent with industry benchmarks
- Staffing costs set at 36% of revenue, scaling incrementally with new hires in Year 2 and Year 3
- Marketing budget fixed at 5% of revenue; reviewed quarterly and adjusted based on channel performance
- No bad debt assumed; payment terms enforced from day one
Funding requirements:
McKenzie Advanced Diagnostics is seeking $320,000 to fund the following:
| Use of funds | Amount |
|---|---|
| Equipment and fit-out | $128,000 |
| Working capital (6 months) | $112,000 |
| Marketing launch | $48,000 |
| Legal, licences, and professional fees | $32,000 |
| Total | $320,000 |